​

In 2024, Dr Walhan Alshaer participated in the International Conference of Medical Laboratory and Health Sciences Research (ICMLH 2024), where he had the opportunity to present his research on nanobiotechnology-based strategies for targeted drug delivery in cancer therapy. The conference served as a dynamic platform to discuss innovative approaches in medical laboratories and health sciences, facilitating interdisciplinary collaboration and the exchange of groundbreaking ideas to advance healthcare research and applications.

​